ICAP
ISEE

Independence Capital Asset Partners’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Independence Capital Asset Partners’s Portfolio ISEE Stock Details ISEE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-249,590
Closed -$8.9M – 116
2014
Q1 		$8.9M Sell
249,590
-118,493
-32% -$4M 1.48% 32
2013
Q4 		$11.9M Sell
368,083
-38,165
-9% -$1.13M 1.81% 21
2013
Q3 		$12.1M Buy
+406,248
New +$11.5M 2.05% 18

Other funds holding ISEE

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SHI
SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return
JCG
JHL Capital Group Chicago, Illinois $805M AUM 50.84% 1-Year Est. Return
CV
Clarus Ventures Cambridge, Massachusetts $425M AUM 26.13% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Independence Capital Asset Partners's ISEE Position: Q2 2014 in Review

Independence Capital Asset Partners sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q2 2014, closing a stake of 249,590 shares — an estimated $8.9M sold.

Independence Capital Asset Partners first reported a position in ISEE in Q3 2013 and held it in 3 quarters. The position peaked at $12.1M in Q3 2013. 98 funds tracked by Wall St. Rank hold ISEE as of Q2 2014.

  • Independence Capital Asset Partners reported no remaining IVERIC bio, Inc. Common Stock position as of Q2 2014 after selling out during the quarter.
  • Independence Capital Asset Partners sold 249,590 IVERIC bio, Inc. Common Stock shares in Q2 2014, an estimated $8.9M.
  • Independence Capital Asset Partners first reported a position in IVERIC bio, Inc. Common Stock in Q3 2013 and held it in 3 quarters.
  • Independence Capital Asset Partners's IVERIC bio, Inc. Common Stock position peaked at $12.1M in Q3 2013.
  • 98 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q2 2014.

Based on Independence Capital Asset Partners's 13F filing for Q2 2014, filed 14 Aug 2014.